FORMER CONGRESSMAN MATT SALMON TO JOIN RAAP
New Hires Greatly Expand RAAP Advocacy Capabilities
Washington, D.C. – The Rare Access Action Project, (RAAP), announced today that former Arizona Congressman Matt Salmon will be joining RAAP as a key advisor on rare disease issues.
“We are very excited to welcome Congressman Salmon to the RAAP family. He brings a wealth of experience and knowledge that will greatly expand RAAP’s capabilities in the Rare Disease space. Specifically, he will provide considerable insight into RAAP’s efforts to build solutions to address access and coverage for rare disease patients and therapies. Congressman Salmon’s leadership and guidance is a game changer for RAAP,” said Mike Eging, Executive Director of RAAP.
“As a member of Congress, I worked with patients, families, and other health care stakeholders to find solutions to our most challenging patient access issues. Today, innovation has offered us the potential for significant advancements, however, we must still contend with an antiquated health care system. It is exciting to join RAAP and work with an organization that has a unique opportunity to advocate for rare patients and help implement modern day solutions,” said Congressman Salmon.
Congressman Salmon joins a RAAP team that has also recently added two new outstanding individuals who bring significant experience in health policy analysis and grassroots organization.
Angela Lively has over 20 years of experience analyzing and determining implications of health and reimbursement policy. Throughout her career, Angela has supported the launch of dozens of products and has specifically focused on how companies should prepare, optimize and address barriers to market access. For RAAP, Angela oversees policy development and analysis.
Jeff Oldham joins RAAP as a public affairs expert who will be in charge of State and Local policy and grassroots outreach. Jeff has over 25 years of experience serving Fortune 500 and trade association clients across the health care spectrum.
“Angela and Jeff have been extraordinary additions to our organization. Their combined experience and abilities have had an immediate impact on RAAP as we continue to work quickly to find solutions for rare disease patients to gain access to the critical therapies they need. We are incredibly fortunate and very happy to have both Angela, Jeff and now Congressman Salmon helping to guide and implement RAAP’s policy objectives to improve patient access to critical therapies,” said Eging.
RAAP, the Rare Access Action Project, is a coalition of life sciences and patient stakeholders that explore creative policy solutions to address structural issues in access and coverage. Our priority is to help ensure rare disease patients have access to the care and treatments they need. RAAP is a registered 501 c4 non-profit organization.